Comparison of neuromuscular blockade recovery co-administered with neostigmine and different doses of calcium gluconate: a randomized control trial

• Published in: BMC anesthesiology 2021-03, Vol.21 (1), p.93-93, Article 93
• Main Authors: Choi, So Ron, Kim, Jeong Ho, Lee, Kyung Hyun, Park, Sang Yoong
• Format: Article
• Language: English
• Subjects: Acetylcholinesterase; Acetylcholinesterase inhibitor; Airway management; Anesthesia; Anesthesia Recovery Period; Atropine; Blood pressure; Blood tests; Body temperature; Calcium; Calcium - blood; Calcium gluconate; Calcium Gluconate - administration & dosage; Communications equipment; Comparative analysis; Cooperation; Depolarization; Dosage; Dose-Response Relationship, Drug; Double-Blind Method; Drug dosages; Electrocardiography; Enzyme inhibitors; Female; Glycopyrrolate; Humans; Laparoscopy; Male; Medical personnel; Middle Aged; Neostigmine; Neostigmine - administration & dosage; Neuromuscular Blockade; Neuromuscular blockade recovery; Neurotransmitter release; Parasympathomimetics - administration & dosage; Patients; Postoperative residual curarization; Statistical analysis; Surgery; Time Factors
• ISSN: 1471-2253; 1471-2253
• DOI: 10.1186/s12871-021-01316-7

Calcium increases the probability of transmitter release at the neuromuscular junction. It is not known whether there is a dose-dependent relationship between the dosage of calcium gluconate and the probability of transmitter release for non-depolarizing neuromuscular blockade (NMB) recovery by acetylcholinesterase inhibitors (AchEIs). This study compared the neuromuscular recovery time and the incidence of postoperative residual curarization (PORC) according to the dosage of calcium gluconate co-administered with neostigmine in three patient groups. Patients were randomly allocated to a control group, a 5 mg/kg calcium gluconate group (calcium 5 group), or a 10 mg/kg calcium gluconate group (calcium 10 group). In patients with a TOF ratio (TOFr) between 0.2-0.7, 0.04 mg/kg of neostigmine was administered and both 0.2 mg of glycopyrrolate and 0.4 mg of atropine per 1 mg of neostigmine were administered. And additional 5 or 10 mg/kg of calcium gluconate were administrated to the calcium 5 and 10 groups. The primary endpoint was neuromuscular recovery time (the time between reversal and TOFr≥0.9). The secondary endpoints were the incidence of PORC at 5, 10, and 20 min after reversal administration and the train-of-four ratio (TOFr) at each time point. The neuromuscular recovery time was 5.3 min in the control group, 3.9 min in the calcium 5 group, and 4.1 min in the calcium 10 group, respectively (P = 0.004). The incidence of PORC at 5 min after neostigmine administration was 12 in the control group, 4 in the calcium 5 group, and 4 in the calcium 10 group, respectively, with statistical significance (P = 0.014). The co-administration of calcium gluconate with neostigmine safely promoted early NMB recovery, and the neuromuscular recovery time of the calcium 10 group tended to be more evenly distributed than that of the calcium 5 group. https://cris.nih.go.kr/cris/index.jsp(KCT0004182 ). Date of registration: August 122,019.